{"id":"https://openalex.org/W1980670925","doi":"https://doi.org/10.1016/0022-1759(93)90139-x","title":"Use of particulate forms of protein antigens to increase the sensitivity of antigen-specific proliferation assays","display_name":"Use of particulate forms of protein antigens to increase the sensitivity of antigen-specific proliferation assays","publication_year":1993,"publication_date":"1993-02-01","ids":{"openalex":"https://openalex.org/W1980670925","doi":"https://doi.org/10.1016/0022-1759(93)90139-x","mag":"1980670925","pmid":"https://pubmed.ncbi.nlm.nih.gov/8445264"},"language":"en","primary_location":{"id":"doi:10.1016/0022-1759(93)90139-x","doi":"https://doi.org/10.1016/0022-1759(93)90139-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0022-1759(93)90139-x","pdf_url":null,"source":{"id":"https://openalex.org/S201669150","display_name":"Journal of Immunological Methods","issn_l":"0022-1759","issn":["0022-1759","1872-7905"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunological Methods","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Wu J.-Y.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wu J.-Y.","raw_affiliation_strings":["Cambridge Biotech Corporation, Worcester, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge Biotech Corporation, Worcester, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061394839","display_name":"Kenneth J. Munroe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K.J. Munroe","raw_affiliation_strings":["Cambridge Biotech Corporation, Worcester, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge Biotech Corporation, Worcester, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012477884","display_name":"B H Gardner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B.H. Gardner","raw_affiliation_strings":["Cambridge Biotech Corporation, Worcester, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge Biotech Corporation, Worcester, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000904446","display_name":"Michael S. Wyand","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.S. Wyand","raw_affiliation_strings":["TSI Mason Research Laboratory, Worcester, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TSI Mason Research Laboratory, Worcester, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088019995","display_name":"Mark J. Newman","orcid":"https://orcid.org/0000-0002-0433-6690","observed_orcids":["https://orcid.org/0000-0002-0433-6690"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"M.J. Newman","raw_affiliation_strings":["Cambridge Biotech Corporation, Worcester, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge Biotech Corporation, Worcester, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5088019995"],"corresponding_institution_ids":[],"apc_list":{"value":2970,"currency":"USD","value_usd":2970},"apc_paid":null,"fwci":0.1148,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.37261698,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"159","issue":"1-2","first_page":"39","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0544000007212162,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.020899999886751175,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/particulate-antigen","display_name":"particulate antigen","score":0.7609999775886536},{"id":"https://openalex.org/keywords/latex-microspheres","display_name":"latex microspheres","score":0.9589999914169312},{"id":"https://openalex.org/keywords/antigen-specific-proliferation","display_name":"antigen-specific proliferation","score":0.8029999732971191},{"id":"https://openalex.org/keywords/hiv-1-gp160","display_name":"HIV-1 gp160","score":0.9520000219345093},{"id":"https://openalex.org/keywords/tetanus-toxoid","display_name":"tetanus toxoid","score":0.9959999918937683},{"id":"https://openalex.org/keywords/rhesus-macaques","display_name":"rhesus monkeys","score":0.8610000014305115},{"id":"https://openalex.org/keywords/vaccine-immunogenicity","display_name":"vaccine immunogenicity","score":0.7829999923706055},{"id":"https://openalex.org/keywords/antibody-response","display_name":"antibody response","score":0.5799999833106995},{"id":"https://openalex.org/keywords/recombinant-protein","display_name":"recombinant protein","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2777351567","wikidata":"https://www.wikidata.org/wiki/Q908822","display_name":"Toxoid","level":4,"score":0.8076246976852417},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.798815131187439},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5453211665153503},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5424543023109436},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.521902859210968},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.5083367228507996},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.45439672470092773},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.4530262351036072},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4415530860424042},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40603095293045044},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.40035712718963623},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16146117448806763},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000941","descriptor_name":"Antigens","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000941","descriptor_name":"Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008253","descriptor_name":"Macaca mulatta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008863","descriptor_name":"Microspheres","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013745","descriptor_name":"Tetanus Toxoid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D015686","descriptor_name":"Gene Products, env","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016915","descriptor_name":"AIDS Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019302","descriptor_name":"HIV Envelope Protein gp160","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0022-1759(93)90139-x","doi":"https://doi.org/10.1016/0022-1759(93)90139-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0022-1759(93)90139-x","pdf_url":null,"source":{"id":"https://openalex.org/S201669150","display_name":"Journal of Immunological Methods","issn_l":"0022-1759","issn":["0022-1759","1872-7905"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunological Methods","raw_type":"journal-article"},{"id":"pmid:8445264","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8445264","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunological methods","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3996530680","display_name":"HIV 1/2 (AIDS) VACCINE DEVELOPMENT USING NOVEL ADJUVANTS","funder_award_id":"U01AI028167","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1515884823","https://openalex.org/W1531831170","https://openalex.org/W1564345420","https://openalex.org/W1564933160","https://openalex.org/W1592148424","https://openalex.org/W1601344030","https://openalex.org/W1767836602","https://openalex.org/W1857197615","https://openalex.org/W1938714948","https://openalex.org/W1946144901","https://openalex.org/W2001679096","https://openalex.org/W2022290983","https://openalex.org/W2030017358","https://openalex.org/W2032721423","https://openalex.org/W2054698489","https://openalex.org/W2075986364","https://openalex.org/W2138032217","https://openalex.org/W2394827802","https://openalex.org/W2407963797","https://openalex.org/W2413469612","https://openalex.org/W2414293199","https://openalex.org/W2421782923","https://openalex.org/W4252530551"],"related_works":["https://openalex.org/W2054698489","https://openalex.org/W2035511347","https://openalex.org/W2048166187","https://openalex.org/W2095304551","https://openalex.org/W2060695106","https://openalex.org/W2020571973","https://openalex.org/W4386171520","https://openalex.org/W2260412793","https://openalex.org/W2379241884","https://openalex.org/W2045893676"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}